Primed to Surpass CRISPR: Prime Medicine Emerges Out of Stealth with $315 Million in Funding
After spending a couple of years in stealth mode, Cambridge, MA-based gene editing startup Prime Medicine has finally emerged on the scene. On July 13th, the company announced its launch …
Read More